国际眼科纵览

• 综述 • 上一篇    下一篇

角膜胶原交联术的远期效果

廖凯  曾庆延   

  1. 430000 武汉,中南大学爱尔眼科学院 武汉爱尔眼科医院汉口医院
  • 收稿日期:2016-03-21 出版日期:2016-08-22 发布日期:2016-09-08
  • 通讯作者: 曾庆延,Email:zengqingyan1972@163.com E-mail:zengqingyan1972@163.com

Long-term efficacy of corneal cross linking

LIAO Kai, ZENG Qing-yan   

  1. Aier Eye Institute of Central South University, Hankou Aier Eye Hospital, Wuhan 430000, China
  • Received:2016-03-21 Online:2016-08-22 Published:2016-09-08
  • Contact: ZENG Qing-yan, Email: zengqingyan1972@163.com E-mail:zengqingyan1972@163.com

摘要:

 角膜胶原交联术(corneal collagen cross linking,CXL)是目前治疗角膜扩张性疾病的有效手段,经典去上皮技术长期效果肯定,但手术时间长,部分患者存在并发症。为提高安全性,CXL技术在不断改良,包括经上皮胶原交联、强紫外线光快速交联等。但这些改良CXL长期有效性尚存争议。去上皮胶原交联仍是目前最有效的胶原交联术式,目前报道的经上皮胶原交联及快速胶原交联的效果良好,但远期效果有待进一步随访研究。

Abstract:

Corneal collagen cross linking has become the most effective treatment for corneal dilated diseases. The effect of tranditional epithelium-off corneal cross linking is well-known, but it take too much time on surgical time, and some patients showed side effects after surgery. In order to improve the surgical safety, some improved surgical techniques have been developed, include transepithelial corneal cross linking and  accelerated corneal cross linking, but there’s a lot of debate about the validity of these. The epithelium-off corneal cross linking is the most effective surgical method for now, the efficacy of epithelium-on and accelerated corneal cross linking in short term was well, but it still needs more long-term results to verify the effectiveness for treating keratoconus.